Phenol esters

Medchemexpress LLC Methyl 4-[8-(hydroxyamino)-8-oxooctanoyl]oxybenzoate | 946150-57-8 | MFCD28986227 | 98.0% | 323.34 | C16H21NO6 | 25 MG

Remetinostat is a hydroxamic acid-based histone deacetylase (HDAC) inhibitor supplied as a white to off-white solid for laboratory research. It has demonstrated efficacy in imiquimod-induced models of psoriatic dermatitis and is used in preclinical studies of cutaneous T-cell lymphoma. The compound is supplied with defined purity and storage recommendations to support reproducible experiments.

• Hydroxamic acid-based histone deacetylase (HDAC) inhibitor.
• Validated activity in psoriatic dermatitis animal models.
• Applicable to studies of cutaneous T-cell lymphoma mechanisms.
• High purity suitable for research (98.0%).
• Stable solid form with recommended cold storage for prolonged shelf life.

Medchemexpress LLC HY-100365 100mg Medchemexpress, Remetinostat CAS:946150-57-8 Purity:>98%

Medchemexpress, HY-100365 100mg Remetinostat CAS:946150-57-8 Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma [1] . Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.